Bing Chen
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
- Molecular Biology top 5%
- Circular RNAs in diseases
- Extracellular vesicles in disease
Papers in
-
- Cancer-related molecular mechanisms research 15
- Breast Cancer Treatment Studies 4
- MicroRNA in disease regulation 2
-
- Circular RNAs in diseases 18
- Co-authors
- Qifeng Yang (44 shared papers)Wenjing Zhao (36 shared papers)Ning Zhang (26 shared papers)Yaming Li (35 shared papers)Hanwen Zhang (21 shared papers)Xiaojin Song (15 shared papers)Ying Liu (19 shared papers)Xiaolong Wang (18 shared papers)
- Journals
- Cell Death and Disease (8 papers)Advanced Science (4 papers)Molecular Therapy — Nucleic Acids (3 papers)Frontiers in Oncology (3 papers)Molecular Therapy (3 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Bing Chen
73 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 73
- Cancer Research 824
- Molecular Biology 1.2k
- Geriatrics and Gerontology 21
- Oncology 113
- Immunology and Allergy 19
Countries citing papers authored by Bing Chen
This map shows the geographic impact of Bing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Chen more than expected).
Fields of papers citing papers by Bing Chen
This network shows the impact of papers produced by Bing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Chen. The network helps show where Bing Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 355 | |
| 2 | 2021 | 190 | |
| 3 | 2014 | 181 | |
| 4 | 2012 | 168 | |
| 5 | 2018 | 158 | |
| 6 | 2022 | 154 | |
| 7 | 2021 | 145 | |
| 8 | 2017 | 126 | |
| 9 | 2019 | 121 | |
| 10 | 2019 | 112 | |
| 11 | 2023 | 91 | |
| 12 | 2003 | 87 | |
| 13 | 2021 | 85 | |
| 14 | 2022 | 80 | |
| 15 | 2019 | 69 | |
| 16 | 2023 | 62 | |
| 17 | 2018 | 61 | |
| 18 | 2018 | 61 | |
| 19 | 2019 | 61 | |
| 20 | 2022 | 55 |
About Bing Chen
Bing Chen is a scholar working on Cancer Research, Molecular Biology, Epidemiology, Genetics and Ophthalmology, having authored 76 papers that have together received 3.3k indexed citations. Recurring topics across this work include Circular RNAs in diseases (18 papers), Cancer-related molecular mechanisms research (15 papers), Breast Cancer Treatment Studies (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), MicroRNA in disease regulation (2 papers), Intraocular Surgery and Lenses (2 papers), Autophagy in Disease and Therapy (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Cancer Research (824 citations), Molecular Biology (1.2k citations), Geriatrics and Gerontology (21 citations), Oncology (113 citations) and Immunology and Allergy (19 citations). Bing Chen has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Qifeng Yang, Wenjing Zhao, Ning Zhang, Yaming Li, Hanwen Zhang, Xiaojin Song, Ying Liu, Xiaolong Wang, Lijuan Wang and Yuting Sang. Their work appears in journals such as Cell Death and Disease, Advanced Science, Molecular Therapy — Nucleic Acids, Frontiers in Oncology and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.